A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
Clinical trial NCT03713658 · COMPLETED
Trial details
- NCT number
- NCT03713658
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2019-12-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.